Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cassier PA et al. – Gemcitabine-oxaliplatin combination (GEMOX) is active and well tolerated in pretreated pts with metastatic neuroendocrine tumors.

Methods

Results

Today in Neuroendocrinology...keeping you current

Evaluation of antioxidant systems in pituitary-adrenal axis diseases
Pituitary, 12/18/09

A heritable predisposition to pituitary tumors
Pituitary, 12/18/09

The risk for breast cancer is not evidently increased in women with hyperprolactinemia
Pituitary, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address